Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone-Lidocaine Mix for TMJ Pain
NCT07445191Phase 3Not yet recruiting
- Sponsor
- Cairo University
- Start
- Mar 2026
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of triamcinolone in temporomandibular joint disorder (TMJ), sponsored by Cairo University. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
triamcinolone
03
Conditions
temporomandibular joint disorder (TMJ)
Beyond the preview
Go deeper on NCT07445191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07445191.